About Sanzyme Biologics
Sanzyme Biologics is a Healthcare company based in Hyderabad (India) founded in 2017. It produces probiotic strains, enzymes, and supplements for health, pharma, and agriculture industries. It operates on a B2B and D2C model in Healthcare and Agriculture sectors. The company has 303 employees. Its Indian entity Sanzyme Biologics Private Limited reported revenue of ₹226 Cr. Sanzyme Biologics offers products and services including Probiotic Strains, Enzymes, Vitamin K2, and Probiotic Oral Suspension. Its focus areas include Biotechnology, Probiotics, Health Supplements and Probiotic Strains.
Company details
Sanzyme Biologics, headquartered in Hyderabad, India, specializes in manufacturing shelf-stable probiotic strains and enzymes. They provide products and services for food supplements, pharmaceuticals, pet food, aquaculture, and environmental solutions. With over five decades of fermentation expertise, they offer contract research, global probiotic applications, and support for various industries including health and agriculture.
- Headquarters Hyderabad, India
- Employees 303
- SectorsHealthcareAgriculture
- Email••••••••
- Phone•••• ••••
- Website sanzymebiologics.com
- Social LinkedIn X Facebook
- Legal Name Sanzyme Biologics Private Limited
- Date of Incorporation 16 Sep, 2016
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹226 Cr
FY 2025 · +15% YoY
- Net Profit₹53.05 Cr
FY 2025 · 23% margin
- EBITDA₹90.36 Cr
FY 2025 · 40% margin
- Employee Count303
Associated legal entities of Sanzyme Biologics
Sanzyme Biologics operates through Sanzyme Biologics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sanzyme Biologics Private Limited CIN U24110TG2016PTC112002 | Active | 16 Sep 2016 | Hyderabad, Telangana | ₹226 Cr | 303 | 5 | View details |
Products & Services of Sanzyme Biologics
Sanzyme Biologics offers a comprehensive portfolio of products and services, including Probiotic Strains, Enzymes, Vitamin K2, and Probiotic Oral Suspension.
Science-backed strains for food, pharma, and agriculture applications
Fermentation-produced enzymes for supplements and pharmaceuticals
Essential nutrient for health and food applications
Suspension for digestive health support
Board of directors of Sanzyme Biologics Private Limited (Sanzyme Biologics)
Sanzyme Biologics Private Limited is the primary company behind Sanzyme Biologics. The board of Sanzyme Biologics Private Limited currently have 4 directors; the longest-serving is Jay Soman, appointed in 2016. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jay Soman DIN 00964215 | Director | 16 Sep 2016 | 10 yrs 1 mo | Sanzyme Biologics Private Limited |
| Surapaneni Sree Rama Koteswara Rao DIN 00964290 | Director | 16 Sep 2016 | 10 yrs 1 mo | Sanzyme Biologics Private Limited |
| Raunak Jay Soman DIN 07622576 | Whole-time director | 21 Oct 2017 | 9 yrs | Sanzyme Biologics Private Limited |
| Dhruv Jay Soman DIN 07622578 | CEO | 14 Sep 2023 | 3 yrs 1 mo | Sanzyme Biologics Private Limited |
People of Sanzyme Biologics
10 people are tracked at Sanzyme Biologics (5 in leadership, 5 in team); the tracked headcount is 303.
| Name | Role | Group |
|---|---|---|
Imtiaz Chaglani | Vice President | Leadership |
| Director | Leadership | |
| CEO | Leadership | |
Harinath Dandu | Head Of Quality Assurance | Leadership |
Phani Prasad Kompella | Deputy General Manager - Supply Chain | Leadership |
Rahul Dapke | Senior Executive | Team |
Rajarshi Dasgupta | Intellectual Property Lawyer | Team |
Dr. M.D. Borhan Uddin | Consultant | Team |
Mutyala Satyanarayana | IT Senior Manager | Team |
Srinivas Rao Konala. Mba-Pmms | Sr. Manager Purchase (scm) | Team |
Complete people profiles for Sanzyme Biologics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Sanzyme Biologics
Figures of Sanzyme Biologics Private Limited, the primary company behind Sanzyme Biologics, for FY 2025. Revenue was ₹226 Cr (+15% year on year). Net profit was ₹53.05 Cr (23% margin). EBITDA was ₹90.36 Cr (40% margin). Revenue has grown at a compounded annual rate of +11% over three years and +12% over five years.
- ₹226 CrRevenue · FY 2025 · +15% YoY
- ₹53.05 CrNet profit · 23% margin
- ₹90.36 CrEBITDA · 40% margin
- ₹1.67 CrPaid-up capital
- 303Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sanzyme Biologics Private Limited are on its company page.
Detailed financial statements for Sanzyme Biologics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Sanzyme Biologics
The website of Sanzyme Biologics (sanzymebiologics.com) receives about 3.8K visits a month.
- Monthly visits3.8K
▼ 6.1% vs previous month
Websites whose visitors overlap most with Sanzyme Biologics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
algaebank.com.mx | algaebank.com.mx | 100% | #9,280,622 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sanzyme Biologics
Complete news archive for Sanzyme Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanzyme Biologics
Sanzyme Biologics was founded in 2017.
Sanzyme Biologics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Sanzyme Biologics has 303 employees.
The primary company behind Sanzyme Biologics, Sanzyme Biologics Private Limited, reported revenue of ₹226 Cr for FY 2025, up 15% year on year.
Sanzyme Biologics, headquartered in Hyderabad, India, specializes in manufacturing shelf-stable probiotic strains and enzymes. They provide products and services for food supplements, pharmaceuticals, pet food, aquaculture, and environmental solutions. With over five decades of fermentation expertise, they offer contract research, global probiotic applications, and support for various industries including health and agriculture.
Sanzyme Biologics offers Probiotic Strains, Enzymes, Vitamin K2, and Probiotic Oral Suspension.
Sanzyme Biologics operates through Sanzyme Biologics Private Limited.
The legal entities of Sanzyme Biologics currently have 5 directors, including Dhruv Soman, Raunak Jay Soman, Dhruv Jay Soman and others.